Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Levisetti: Absence of lymph nodes in NOD mice treated with lymphotoxin-β receptor immunoglobulin.... (0.18 sec) 

Absence of lymph nodes in NOD mice treated with lymphotoxin-β receptor immunoglobulin …

- diabetesjournals.org
MG Levisetti, A Suri, K Frederick, ER Unanue - Diabetes, 2004 - Am Diabetes Assoc
Pregnant nonobese diabetic (NOD) mice were treated with lymphotoxin-β receptor
immunoglobulin fusion protein (LTβR-Ig) or control human immunoglobulin on days
embryonic day 11 (E11) and E14, and offspring were followed for the ...
Cited by 19 - Related articles - BL Direct - All 5 versions

[CITATION] Immunotherapy of type 1 diabetes mellitus


L Chatenoud, 2000 - content.karger.com
Type 1 diabetes mellitus (T1D) is a T-cell-mediated autoimmune disease [1, 2].
It is thus logical to modulate the immune system to stop the progression of the
disease as it is widely done for other autoimmune diseases. T1D presents, ...
Cited by 3 - Related articles - All 4 versions

Diabetes Is Predicted by the {beta} Cell Level of Autoantigen

- jimmunol.org
CA Byersdorfer, GG Schweitzer, ER Unanue - The Journal of Immunology, 2005 - Am Assoc Immnol
Two novel transgenic (Tg) strains were created expressing hen egg-white lysozyme
(HEL) in a pancreas-specific fashion. RmHP.111 mice had levels of HEL per cell
similar to that of the established ILK-3 strain, while RmHP.117 mice had ...
Cited by 5 - Related articles - BL Direct - All 4 versions

[CITATION] Devising murine models to better adapt clinical protocols: sequential low-dose treatment …


HH Campos, JF Bach, L Chatenoud - Transplantation proceedings, 1993 - cat.inist.fr
Devising murine models to better adapt clinical protocols: sequential low-dose
treatment with anti-CD 3 and anti-CD 4 monoclonal antibodies to prevent fully ...
Cited by 5 - Related articles - BL Direct - All 2 versions

Downregulation of IL-12 and a novel negative feedback system mediated by CD25+ CD4+ T …


K Sato, S Tateishi, K Kubo, T Mimura, K … - Biochemical and Biophysical Research …, 2005 - Elsevier
CD25 + CD4 + regulatory T cells suppress immune responses and are believed to
play roles in preventing autoimmune diseases. However, the mechanism(s)
underlying the suppression and the regulation of their homeostasis remain ...
Cited by 14 - Related articles - All 4 versions

Pancreatic lymph nodes are required for priming of {beta} cell reactive T cells in NOD mice

- rupress.org
MC Gagnerault, JJ Luan, C Lotton, F Lepault - Journal of Experimental Medicine, 2002 - jem.rupress.org
Nonobese diabetic (NOD) mice develop spontaneous autoimmune diabetes that
results from the destruction of insulin secreting ß cells by diabetogenic T
cells. The time and location of the encounter of autoantigen(s) by naive ...
Cited by 94 - Related articles - BL Direct - All 6 versions

Role of L-selectin in the development of autoimmune diabetes in non-obese diabetic mice

- oxfordjournals.org
C Mora, IS Grewal, FS Wong, RA Flavell - International immunology, 2004 - Jpn Soc Immunol
Autoimmune diabetes is characterized by an early mononuclear infiltration of
pancreatic islets and later selective autoimmune destruction of
insulin-producing ß cells. Lymphocyte homing receptors have been ...
Cited by 7 - Related articles - All 3 versions

Selective generation of gut-tropic T cells in gut-associated lymphoid tissues: requirement …


M Svensson, B Johansson-Lindbom, MA … - Ann NY Acad Sci, 2004 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 7 - Related articles - All 6 versions

[CITATION] In-vivo anti-CD3 treatment of autoimmune patients.


L Chatenoud, C Ferran, JF Bach - Lancet, 1989 - ncbi.nlm.nih.gov
1: Lancet. 1989 Jul 15;2(8655):164. Comment on: Lancet. 1989 Jun
17;1(8651):1390. In-vivo anti-CD3 treatment of autoimmune patients. ...
Cited by 10 - Related articles - All 3 versions

Autoimmune ovarian disease in day 3-thymectomized mice: the neonatal time window, antigen …


KS Tung, YY Setiady, ET Samy, J Lewis, C … - Current topics in microbiology and immunology, 2005 - ncbi.nlm.nih.gov
Discovery of the CD4+CD25+ T cells has stemmed from investigation of the AOD in
the d3tx mice. Besides CD4+CD25+ T cell depletion, d3tx disease induction
requires effector T cell activation prompted by lymphopenia. This is ...
Cited by 10 - Related articles - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google